Harrison Stafford

Had to add this one as well. As legend has it, the members of Iron Butterfly were so stoned when they recorded the track that they could neither pronounce the title “In the Garden of Eden” or end the track, so it ended up filling the whole side of the album coming in at a full 17 minutes of psychedelic rock.

One of the earliest psychedelic tunes.

Oh, they’ll be riled up soon enough.

Making friends and making money. Why not both?

GERN’s AdCom date is this Thursday. March 14th. That committee will decide if GERN’s drug, Imetelstat, should be submitted to the FDA for approval. I think the drug works. Lengthening the time between transfusions generally increases survival. Imetelstat treats the cause not just the symptoms and is therefore a disease modifying drug. And, if this one gets recommended and approved, the next phase 3 is treating myelofibrosis using the same drug… It should be approved as well. So, if there’s a green light for GERN on Thursday, I expect the stock to move a couple bucks (it’s currently at $2.23). It’s the FDA decision that will have the biggest impact on the share price. The PDUFA, target date is in May, but after AdCom, the FDA doesn’t have to wait that long to make a decision and they could decide to give the drug approval much earlier. Have owned GERN for eleven l-o-n-g years and we’re at the finish line. If Imetelstat is not approved, it’s likely the beginning of the end for Geron. This is Biotech and it’s as close as you can get to a casino. Long GERN 6000 shares at a cost basis of $3.19. IBRX +.48 to $5.53. The PDUFA date for IBRX’s drug, Anktiva, is April 23rd. Anktiva has, virtually, no side effects and is better than the current standard of care…..what’s not to like. Long IBRX 27,800 shares at a cost basis of $9.77.

I like any offensive lineman that’s not Kenyon Green.

Post game, Sengun said he did it for Tari.

I’m an old (just became a septuagenarian) and I have never seen a college QB who could take over a game like Vincent Paul Young Jr. He’s the Magic Man.

Billie Jean King was carried like Cleopatra into the Astrodome in Houston. And Riggs popping 415 vitamins/day before that match was muy unhealthy.

EOSE earnings after the bell with the conference call tomorrow morning. Waiting on the DOE loan.

I feel rich when listening to Sinatra.

I want to laugh like rich people laugh.

Andy’s OD’d on bacon at least three times.

Run Zay, run!

I have skin in the game and you have no skin in the game. Let’s see who gets the last laugh.

So, you come on here, shit on a stock, but you won’t even take a short position?

We’re on opposite sides of this trade. Let’s see who gets the last laugh.

https://recyclico.com/recyclico-battery-materials-and-zenith-chemical-announce-a-us25-million-lithium-ion-battery-recycling-joint-venture-in-taiwan/ Ever heard of Zenith?

AMYZF +.04 to .15. A 38% move. You bash the stock and up it goes. Can we haz u come back every trading day?

And AMYZF has to about double from here for the rights to be in the money. That’s a start.

As at October 2023, RecycLiCo Battery Materials (AMYZF) had cash of CA$19m and no debt. In the last year, its cash burn was CA$4.4m. Based on that, from October 2023 it has 4.3 years of cash runway. This has been a horrible investment, but it ain’t over.